Electrolytes and sodium (salt tablets and electrolyte drinks) trials recruiting now
2 registrations that name electrolytes and sodium as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.
Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.
Filter 2 registrations
Status
Phase
1US sites across 1 state
1
2 to 4
5 to 19
20 or more
All 2 registrations
RecruitingNCT05759078
Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion
Phase 4
Wroclaw Medical University
About 1,000 people
Started Sep 22, 2022
In plain words A Phase 4 study of electrolytes and sodium in people 18 to 90, run by Wroclaw Medical University. It plans to enroll about 1,000 people at 43 sites, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 90. Conditions: Myocardial Infarction, Acute.
Age ≥18 years;
Diagnosis of AMI (STEMI or NSTEMI) up to 4 weeks (28 days) before randomisation
Presence of iron deficiency (ID) defined as transferrin saturation TSAT<20% assessed within up to 4 weeks (28 days) before randomisation;
Presence of ≥3 factors (confirmed within up to 4 weeks before randomisation) (note: at least one of a-c must be present):
10 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Ferinject; Sodium Chloride 0.9% Inj
Registered summary
Non-commercial, multicentre, randomised, double-blind, parallel group, placebo-controlled clinical trial. Eligible patients were randomly assigned (1:1) using a secure, central, interactive, web-based response system, to intervention FCM or placebo arm. Time of observation: minimum of 8 months up to a maximum of 36 months. Primary Study Objective: Primary: Evaluation of the effect of i.v. The full summary is on the listing.
Where, as registered
No US site; Poland (43).
Not yet recruitingNCT07700368
Effect of Monosodium Glutamate on Microbiome-Derived Imidazole Propionate Production in Healthy Volunteers
No phase
University of Chicago
About 18 people
Starts Jul 15, 2026 (estimated)
In plain words A study of electrolytes and sodium in people 18 and older, run by University of Chicago. It plans to enroll about 18 people at 1 US site.
Who it lists and where
Who the trial lists, as registered
Lists people 18 and older; healthy volunteers accepted. Conditions: Healthy Adult.
The goal of this clinical trial is to learn whether dietary monosodium glutamate (MSG), a common food flavor enhancer, increases the blood level of a gut-microbiome-derived compound called imidazole propionate (ImP) in healthy adult volunteers. ImP is a compound made by gut bacteria from the amino acid histidine, and higher blood levels have been linked to problems with blood-sugar control. The full summary is on the listing.
Where, as registered
1 US site in 1 state.
ClinicalTrials.gov lists 2,965 open registrations for this search, including ones where electrolytes and sodium is not a study arm or that are past the 2 we keep. Search them on ClinicalTrials.gov (opens in new tab).